Skip to content

Smart Pharma

Active
Private limited company (pre-2019)founded 201511 yrs activeWaterloose Steenweg 606A, 1050 Elsene, BelgiumKBO/BCE: BE 0588.980.436
Summary

The computed 12-month bankruptcy probability of Smart Pharma is 1.6% (moderate). The 2025 annual accounts show equity of €84,109 and a net result of -€37,265. Equity is growing by ~3.5% per year across the filed fiscal years. Its solvency ranks better than 27% of 10519 sector peers (fiscal year 2025). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes · tick = 2024
Profitability9=
Solvency42▼-8
Growth52=
Track record100
Bankruptcy probability, 12 months
1.6% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,500 at 30 days only on tighter terms
Liquidity short (current ratio 0.9 against 1.15 in 2024; short-term debt: 48.9% and cash: 3.1% of total assets), and 82.6% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
17.4%
Return on assets
-7.7%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 11 years 0 20 y
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€37,265
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
24 d late
2024
1 d early
2023
22 d late
2022
30 d late
2021
4 d early
2020
37 d early
2019
35 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average on the deadline day; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

Smart Pharma was incorporated on 29 January 2015.1 Total assets fell from EUR 686,407 in 2018 to EUR 483,477 in 2025 and headcount from 0.7 full-time equivalents in 2021 to 1.1 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018, 2021 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€37,265▲ 3.0%
2024 · -€38,424
Working capital
-€22,847
2024 · €28,006
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€42,421▼ 56.7%€8,120▼ 80.9%€8,435▲ 3.9%-€30,241-€29,564▲ 2.2%
Net result€24,707within the sector's middle half▼ 67.1%-€1,055within the sector's middle half-€536within the sector's middle half▲ 49.2%-€38,424below the sector's middle half▼ 7,065%-€37,265below the sector's middle half▲ 3.0%
Equity€161,390within the sector's middle half▲ 18.1%€160,335within the sector's middle half▼ 0.7%€159,798within the sector's middle half▼ 0.3%€121,374within the sector's middle half▼ 24.0%€84,109within the sector's middle half▼ 30.7%
Total assets€595,111within the sector's middle half▼ 8.2%€549,581within the sector's middle half▼ 7.7%€503,937within the sector's middle half▼ 8.3%€490,603within the sector's middle half▼ 2.6%€483,477within the sector's middle half▼ 1.5%
Debt€433,722▼ 15.2%€389,246▼ 10.3%€344,138▼ 11.6%€369,228▲ 7.3%€399,368▲ 8.2%
Working capital€100,792within the sector's middle half▲ 11.8%€86,582within the sector's middle half▼ 14.1%€66,793within the sector's middle half▼ 22.9%€28,006within the sector's middle half▼ 58.1%-€22,847below the sector's middle half
Solvency27.1%within the sector's middle half▲ 6.0pp29.2%within the sector's middle half▲ 2.1pp31.7%within the sector's middle half▲ 2.5pp24.7%within the sector's middle half▼ 7.0pp17.4%within the sector's middle half▼ 7.3pp
Current ratio1.71within the sector's middle half▲ 0.211.63within the sector's middle half▼ 0.081.51within the sector's middle half▼ 0.131.15within the sector's middle half▼ 0.350.90below the sector's middle half▼ 0.25
Return on assets (ROA)4.2%within the sector's middle half▼ 7.5pp-0.2%within the sector's middle half▼ 4.3pp-0.1%within the sector's middle half▲ 0.1pp-7.8%below the sector's middle half▼ 7.7pp-7.7%below the sector's middle half▲ 0.1pp
Staff (FTE)0.7below the sector's middle half1below the sector's middle half▲ 42.9%1below the sector's middle half=1below the sector's middle half=1.1below the sector's middle half▲ 10.0%
above within below the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
-€50,000-€25,000€0€25,000€50,000Operating result 2021: €42,421€42,421Net result 2021: €24,707€24,707Operating result 2022: €8,120€8,120Net result 2022: -€1,055-€1,055Operating result 2023: €8,435€8,435Net result 2023: -€536-€536Operating result 2024: -€30,241-€30,241Net result 2024: -€38,424-€38,424Operating result 2025: -€29,564-€29,564Net result 2025: -€37,265-€37,26520212022202320242025-€40,000-€20,000€0Operating result 2023: €8,435€8,430Net result 2023: -€536-€536Operating result 2024: -€30,241-€30,200Net result 2024: -€38,424-€38,400Operating result 2025: -€29,564-€29,600Net result 2025: -€37,265-€37,300202320242025
The operating result stays negative: a loss of €29,564 in 2025 against €30,241 in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €483,477
Fixed assets €269,873 ▼ 4.1%
Current assets €213,605 ▲ 2.1%
Equity and liabilities €483,477
Equity €84,109 ▼ 30.7%
Debt €399,368 ▲ 8.2%
Debt's share of the balance-sheet total rises from 75.3% to 82.6%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
-€18,015▼
2024 · -€4,314
Cash flow
-€25,716▼
2024 · -€12,496
Quick ratio
0.45▲
2024 · 0.45
Debt to equity
4.75▲
2024 · 3.04
ROE
-44.3%▼
2024 · -31.7%
Interest coverage
-2.34▼
2024 · -0.53
Debt ≤ 1 year
€236,451▲
2024 · €181,175
Debt > 1 year
€161,353▼
2024 · €186,344
Staff costs
€73,872▲
2024 · €68,963
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,166 companies that looked in July 2024 the way this one looks now, 2.2% went bankrupt within 24 months and 94% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 10 to 30%
  • a small loss
2.2% went bankrupt
3.0% stopped otherwise
94% still going

A further 0.9% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 1.6% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,166 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 45 lines
Balance sheet Code20242025
Assets
Total assets20/58€490,603€483,477▼
Fixed assets21/28€281,422€269,873▼
Tangible fixed assets22/27€281,422€269,873▼
Land and buildings22€274,462€265,210▼
Plant, machinery and equipment23€6,959€4,663▼
Current assets29/58€209,181€213,605▲
Stocks and contracts in progress3€128,463€107,503▼
Stocks30/36€128,463€107,503▼
Amounts receivable within one year40/41€68,079€88,384▲
Trade receivables40€35,248€36,168▲
Other amounts receivable41€32,831€52,216▲
Cash at bank and in hand54/58€9,880€15,179▲
Deferred charges and accrued income490/1€2,760€2,539▼
Equity and liabilities
Total equity and liabilities10/49€490,603€483,477▼
Equity10/15€121,374€84,109▼
Contributions10/11€6,200€6,200=
Reserves13€1,860€1,860=
Non-distributable reserves130/1€1,860€1,860=
Reserves not available under the articles1311€1,860€1,860=
Profit (loss) carried forward14€113,314€76,049▼
Amounts payable17/49€369,228€399,368▲
Amounts payable after more than one year17€186,344€161,353▼
Financial debts170/4€186,344€161,353▼
Amounts payable within one year42/48€181,175€236,451▲
Current portion of amounts payable after more than one year42€25,901€24,991▼
Trade debts44€76,232€96,409▲
Suppliers440/4€76,232€96,409▲
Taxes, remuneration and social security45€11,995€17,732▲
Taxes450/3-€2,209
Remuneration and social security454/9€11,995€15,522▲
Other amounts payable47/48€67,047€97,320▲
Accrued charges and deferred income492/3€1,709€1,563▼
Income statement Code20242025
Remuneration, social security and pensions62€68,963€73,872▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€25,928€11,549▼
Other operating charges640/8€0€1▲
Gross operating margin9900€64,649€55,858▼
Operating profit (loss)9901-€30,241-€29,564▲
Financial charges65/66B€8,182€7,701▼
Recurring financial charges65€8,182€7,701▼
Profit (loss) for the period before taxes9903-€38,424-€37,265▲
Profit (loss) for the period9904-€38,424-€37,265▲
Profit (loss) for the period to be appropriated9905-€38,424-€37,265▲
Appropriation of the result
Profit (loss) to be appropriated9906€113,314€76,049▼
Profit (loss) brought forward from the previous period14P€151,738€113,314▼
Social balance
Average headcount (FTE)90871.01.1▲

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Remuneration, social security and pensions62€38,818€62,519€61,866€68,963€73,872▲ 7.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€26,116€26,532€33,429€25,928€11,549▼ 55.5%
Other operating charges640/8--€0€0€1▲ 6,000%
Non-recurring operating charges66A€6-----
Gross operating margin9900€107,361€97,170€103,730€64,649€55,858▼ 13.6%
Operating profit (loss)9901€42,421€8,120€8,435-€30,241-€29,564▲ 2.2%
Financial income75/76B€430€409€284---
Recurring financial income75€430€409€284---
Financial charges65/66B€9,964€9,583€9,255€8,182€7,701▼ 5.9%
Recurring financial charges65€9,964€9,583€9,255€8,182€7,701▼ 5.9%
Profit (loss) for the period before taxes9903€32,888-€1,055-€536-€38,424-€37,265▲ 3.0%
Income taxes67/77€8,181-----
Profit (loss) for the period9904€24,707-€1,055-€536-€38,424-€37,265▲ 3.0%
Profit (loss) for the period to be appropriated9905€24,707-€1,055-€536-€38,424-€37,265▲ 3.0%
Line20212022202320242025Change
Assets
Total assets20/58€595,111€549,581€503,937€490,603€483,477▼ 1.5%
Fixed assets21/28€353,019€326,487€305,250€281,422€269,873▼ 4.1%
Intangible fixed assets21€39,000€26,000€13,000---
Tangible fixed assets22/27€314,019€300,487€292,250€281,422€269,873▼ 4.1%
Land and buildings22€296,672€287,632€283,714€274,462€265,210▼ 3.4%
Plant, machinery and equipment23€17,347€12,855€8,536€6,959€4,663▼ 33.0%
Current assets29/58€242,093€223,094€198,686€209,181€213,605▲ 2.1%
Stocks and contracts in progress3€144,844€124,978€131,238€128,463€107,503▼ 16.3%
Stocks30/36€144,844€124,978€131,238€128,463€107,503▼ 16.3%
Amounts receivable within one year40/41€38,320€64,521€50,397€68,079€88,384▲ 29.8%
Trade receivables40€37,000€33,627€32,106€35,248€36,168▲ 2.6%
Other amounts receivable41€1,319€30,894€18,291€32,831€52,216▲ 59.0%
Cash at bank and in hand54/58€55,337€28,207€16,948€9,880€15,179▲ 53.6%
Deferred charges and accrued income490/1€3,591€5,387€104€2,760€2,539▼ 8.0%
Equity and liabilities
Total equity and liabilities10/49€595,111€549,581€503,937€490,603€483,477▼ 1.5%
Equity10/15€161,390€160,335€159,798€121,374€84,109▼ 30.7%
Contributions10/11€6,200€6,200€6,200€6,200€6,200=
Reserves13€1,860€1,860€1,860€1,860€1,860=
Non-distributable reserves130/1€1,860€1,860€1,860€1,860€1,860=
Reserves not available under the articles1311€1,860€1,860€1,860€1,860€1,860=
Profit (loss) carried forward14€153,330€152,275€151,738€113,314€76,049▼ 32.9%
Amounts payable17/49€433,722€389,246€344,138€369,228€399,368▲ 8.2%
Amounts payable after more than one year17€292,421€252,734€212,245€186,344€161,353▼ 13.4%
Financial debts170/4€292,421€252,734€212,245€186,344€161,353▼ 13.4%
Amounts payable within one year42/48€141,300€136,512€131,893€181,175€236,451▲ 30.5%
Current portion of amounts payable after more than one year42€38,903€39,687€40,489€25,901€24,991▼ 3.5%
Trade debts44€62,059€54,404€62,771€76,232€96,409▲ 26.5%
Suppliers440/4€62,059€54,404€62,771€76,232€96,409▲ 26.5%
Taxes, remuneration and social security45€3,844€10,941€7,531€11,995€17,732▲ 47.8%
Taxes450/3-€1,106€66-€2,209-
Remuneration and social security454/9€3,844€9,834€7,464€11,995€15,522▲ 29.4%
Other amounts payable47/48€36,495€31,480€21,103€67,047€97,320▲ 45.2%
Accrued charges and deferred income492/3---€1,709€1,563▼ 8.5%
Line20212022202320242025Change
Profit (loss) for the period9904€24,707-€1,055-€536-€38,424-€37,265▲ 3.0%
+ Depreciation and write-downs630€26,116€26,532€33,429€25,928€11,549▼ 55.5%
Operating cash flow (approximation)€50,823€25,477€32,893-€12,496-€25,716▼ 106%
Investment in fixed assets (approximation)-€0-€12,193-€2,099€0▲ 100%
Change in cash--€27,131-€11,259-€7,068€5,299▲ 175%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
24-08
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema · 24 days late
2025
30-07
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial Weakest financial yearnet -€38,424
Net result drops to -€38,424, the lowest in the series; recovery starts the following year.
22-08
NBB filing Annual accounts filed
fiscal year 2023 · full schema · 22 days late
2023
30-08
NBB filing Annual accounts filed
fiscal year 2022 · full schema · 30 days late
2022
27-07
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial Equity above €150,000Eq €161,390 ▲18.1%
4 profitable years in a row build equity to €161,390.
24-06
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial Highest result since 2018net €75,204 ▲48.2%
Operating result €98,015, net result €75,204, both a record.
31-12
Financial Equity above €100,000Eq €136,683 ▲40.2%
3 profitable years in a row build equity to €136,683.
26-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
19-07
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
27-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
03-07
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts

We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2015
seat establishment The establishment unit on the map
Ground area
273 m²
Building footprint
264 m²
Volume, LiDAR
4,774 m³
Parcel 21447B0274/00W009, Brussels · tallest building 21.8 m, ±6 floors. Linked by address, not a title deed.
1 establishment unit
PHARMACIE
Waterloose Steenweg 606, 1050 ElseneReal estate development
since 20152.241.404.536
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21447B0274/00W009 Brussels 273 m² 1 · 264 m² 21.8 m · 6 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 owner

Chain of control

  1. ROZENTAL & HERMAN 100%
  2. Smart Pharma

Highest known parent: ROZENTAL & HERMAN. The sources do not say who stands above it.

Owners 1

Holdings 0

No holding stated in the accounts, acts or LEI register we read.

According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,294 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company (pre-2019)
Founded29-01-2015
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
68121Development of residential building projects
46150Agents in the wholesale of furniture, household goods and hardware
46190Agents in non-specialised wholesale trade
46460Wholesale of pharmaceutical and medical goods
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
64999Other financial services
68201Renting and operating of own or leased residential real estate, excluding social housing
68310Real estate agency activities
70200Business and other management consultancy
85599Other education
E-invoicing
Reachable via Peppol
Peppol ID 0208:0588980436
Also 9925:BE0588980436
Registered 26-11-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.